| Association between serum fibroblast growth factor 21 and diabetic nephropathy. | |
| | |
MedLine Citation:
|
PMID: 22136913 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Fibroblast growth factor 21 (FGF-21) is a new metabolic regulator with beneficial effects on lipid and glucose metabolism in animal models of diabetes mellitus. The aim of this study was to explore the relationship between FGF-21 and diabetic nephropathy in humans. Serum FGF-21 levels were determined in groups of control (n = 50) and type 2 diabetes mellitus (T2DM) patients with normoalbuminuria (n = 158), microalbuminuria (n = 68), and macroalbuminuria (n = 38) using enzyme-linked immunosorbent assay. Multiple linear regression models were used to analyze the associations between FGF-21 or other biomedical indices and urinary albumin excretion (UAE). Median serum FGF-21 levels were increased in T2DM patients compared with nondiabetic controls and were significantly higher in patients of higher UAE group. In groups of control and T2DM patients with normoalbuminuria, microalbuminuria, and macroalbuminuria, median serum (interquartile range) FGF-21 levels were 467.89 (294.59-519.56), 492.30 (354.59-640.42), 595.01 (480.49-792.31), and 665.20 (448.68-829.75) ng/L (P < .001), respectively. After adjustment for the confounders, FGF-21, fasting plasma glucose, and high-density lipoprotein cholesterol levels were found to be independently associated with UAE in diabetic patients. Serum FGF-21 level is independently correlated with UAE in T2DM patients, indicating that circulating FGF-21 may be involved in diabetic nephropathy. |
| | |
Authors:
|
Wei-Xia Jian; Wen-Hui Peng; Jie Jin; Xue-Ru Chen; Wen-Jun Fang; Wei-Xing Wang; Li Qin; Yan Dong; Qing Su |
Related Documents
:
|
8684783 - The pathogenesis of diabetes-associated congenital malformations. 21570643 - The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients. 15984973 - Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis c an... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-1 |
Journal Detail:
|
Title: Metabolism: clinical and experimental Volume: - ISSN: 1532-8600 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375267 Medline TA: Metabolism Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: a meta-analysis inc...
Next Document: Surgical hemostatic agents: Assessment of drugs and medical devices.